ABUS
Price:
$3.18
Market Cap:
$602.58M
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated N-acetylgalactosamine (GalNAc) delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication. The company's research and development programs include AB-161, an oral HBV RNA destabilizer to destab...[Read more]
Industry
Biotechnology
IPO Date
2007-07-26
Stock Exchange
NASDAQ
Ticker
ABUS
According to Arbutus Biopharma Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 572.18M. This represents a change of 11.83% compared to the average of 511.68M of the last 4 quarters.
The mean historical Enterprise Value of Arbutus Biopharma Corporation over the last ten years is 219.48M. The current 572.18M Enterprise Value has changed 25.97% with respect to the historical average. Over the past ten years (40 quarters), ABUS's Enterprise Value was at its highest in in the September 2024 quarter at 697.24M. The Enterprise Value was at its lowest in in the September 2019 quarter at 370.76K.
Average
219.48M
Median
226.93M
Minimum
35.46M
Maximum
397.34M
Discovering the peaks and valleys of Arbutus Biopharma Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 379.51%
Maximum Annual Enterprise Value = 397.34M
Minimum Annual Increase = -86.07%
Minimum Annual Enterprise Value = 35.46M
Year | Enterprise Value | Change |
---|---|---|
2023 | 397.34M | 22.98% |
2022 | 323.10M | 5.38% |
2021 | 306.62M | 39.40% |
2020 | 219.95M | 68.83% |
2019 | 130.28M | -25.52% |
2018 | 174.91M | -25.22% |
2017 | 233.91M | 97.26% |
2016 | 118.58M | 234.36% |
2015 | 35.46M | -86.07% |
2014 | 254.68M | 379.51% |
The current Enterprise Value of Arbutus Biopharma Corporation (ABUS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
342.35M
5-year avg
275.46M
10-year avg
219.48M
Arbutus Biopharma Corporation’s Enterprise Value is greater than VBI Vaccines Inc. (39.99M), less than ADMA Biologics, Inc. (4.14B), greater than Adaptimmune Therapeutics plc (55.99M), greater than Affimed N.V. (23.63M), greater than Corvus Pharmaceuticals, Inc. (310.53M),
Company | Enterprise Value | Market cap |
---|---|---|
39.99M | $1.87M | |
4.14B | $4.12B | |
55.99M | $148.11M | |
23.63M | $18.88M | |
310.53M | $314.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arbutus Biopharma Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arbutus Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Arbutus Biopharma Corporation's Enterprise Value?
What is the highest Enterprise Value for Arbutus Biopharma Corporation (ABUS)?
What is the 3-year average Enterprise Value for Arbutus Biopharma Corporation (ABUS)?
What is the 5-year average Enterprise Value for Arbutus Biopharma Corporation (ABUS)?
How does the current Enterprise Value for Arbutus Biopharma Corporation (ABUS) compare to its historical average?